Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy

被引:76
|
作者
Campi, Irene [1 ,2 ,3 ]
Gennari, Luigi [4 ]
Merlotti, Daniela [4 ]
Mingiano, Christian [4 ]
Frosali, Alessandro [4 ]
Giovanelli, Luca [1 ,2 ,5 ]
Torlasco, Camilla [6 ,7 ]
Pengo, Martino F. [6 ,7 ]
Heilbron, Francesca [6 ,7 ]
Soranna, Davide [8 ]
Zambon, Antonella [8 ,9 ]
Di Stefano, Marta [1 ,2 ,5 ]
Aresta, Carmen [1 ,2 ,5 ]
Bonomi, Marco [1 ,2 ,5 ]
Cangiano, Biagio [1 ,2 ,5 ]
Favero, Vittoria [1 ,2 ,5 ]
Fatti, Letizia [1 ,2 ,5 ]
Perego, Giovanni Battista [6 ]
Chiodini, Iacopo [1 ,2 ,5 ]
Parati, Gianfranco [6 ,7 ]
Persani, Luca [1 ,2 ,5 ]
机构
[1] Ist Auxol Italiano, Dept Endocrine & Metab Dis, IRCCS, Via Magnasco 2, I-20149 Milan, Italy
[2] Ist Auxol Italiano, Lab Endocrine & Metab Res, IRCCS, Via Magnasco 2, I-20149 Milan, Italy
[3] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[4] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[5] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[6] Ist Auxol Italiano, Dept Cardiovasc Neural & Metab Sci, IRCCS, Milan, Italy
[7] Univ Milano Bicocca, Dept Med & Surg, I-20100 Milan, Italy
[8] IRCCS Ist Auxol Italiano, Biostat Unit, Milan, Italy
[9] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy
关键词
Vitamin D; COVID-19; Mortality; Interleukin-6; TOCILIZUMAB; DEFICIENCY; RISK;
D O I
10.1186/s12879-021-06281-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Vitamin D deficiency has been suggested to favor a poorer outcome of Coronavirus disease-19 (COVID-19). We aimed to assess if 25-hydroxyvitamin-D (25OHD) levels are associated with interleukin 6 (IL-6) levels and with disease severity and mortality in COVID-19. Methods We prospectively studied 103 in-patients admitted to a Northern-Italian hospital (age 66.1 +/- 14.1 years, 70 males) for severely-symptomatic COVID-19. Fifty-two subjects with SARS-CoV-2 infection but mild COVID-19 symptoms (mildly-symptomatic COVID-19 patients) and 206 subjects without SARS-CoV-2 infection were controls. We measured 25OHD and IL-6 levels at admission and focused on respiratory outcome during hospitalization. Results Severely-symptomatic COVID-19 patients had lower 25OHD levels (18.2 +/- 11.4 ng/mL) than mildly-symptomatic COVID-19 patients and non-SARS-CoV-2-infected controls (30.3 +/- 8.5 ng/mL and 25.4 +/- 9.4 ng/mL, respectively, p < 0.0001 for both comparisons). 25OHD and IL-6 levels were respectively lower and higher in severely-symptomatic COVID-19 patients admitted to intensive care Unit [(ICU), 14.4 +/- 8.6 ng/mL and 43.0 (19.0-56.0) pg/mL, respectively], than in those not requiring ICU admission [22.4 +/- 1.4 ng/mL, p = 0.0001 and 16.0 (8.0-32.0) pg/mL, p = 0.0002, respectively]. Similar differences were found when comparing COVID-19 patients who died in hospital [13.2 +/- 6.4 ng/mL and 45.0 (28.0-99.0) pg/mL] with survivors [19.3 +/- 12.0 ng/mL, p = 0.035 and 21.0 (10.5-45.9) pg/mL, p = 0.018, respectively). 25OHD levels inversely correlated with: i) IL-6 levels (rho - 0.284, p = 0.004); ii) the subsequent need of the ICU admission [relative risk, RR 0.99, 95% confidence interval (95%CI) 0.98-1.00, p = 0.011] regardless of age, gender, presence of at least 1 comorbidity among obesity, diabetes, arterial hypertension, creatinine, IL-6 and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count; iii) mortality (RR 0.97, 95%CI, 0.95-0.99, p = 0.011) regardless of age, gender, presence of diabetes, IL-6 and C-reactive protein and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count. Conclusion In our COVID-19 patients, low 25OHD levels were inversely correlated with high IL-6 levels and were independent predictors of COVID-19 severity and mortality.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] COVID-19 severity in relation to sociodemographics and vitamin D use
    Abdulateef, Darya Saeed
    Rahman, Heshu Sulaiman
    Salih, Jamal Mahmood
    Osman, Sangar Mahmoud
    Mahmood, Trifa Abdalla
    Omer, Shirwan Hama Salih
    Ahmed, Rana Adnan
    OPEN MEDICINE, 2021, 16 (01): : 591 - 609
  • [22] Role of vitamin D in pathogenesis and severity of COVID-19 infection
    Honardoost, Maryam
    Ghavideldarestani, Maryam
    Khamseh, Mohammad E.
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2023, 129 (01) : 26 - 32
  • [23] Association of vitamin D status with COVID-19 and its severity
    Bae, Jae Hyun
    Choe, Hun Jee
    Holick, Michael F.
    Lim, Soo
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2022, 23 (03) : 579 - 599
  • [24] Association of Vitamin D with severity and outcome of COVID-19: Clinical and Experimental Evidence
    Renieris, Georgios
    Foutadakis, Spyros
    Andriopoulou, Theano
    Spanou, Victoria-Marina
    Droggiti, Dionysia-Eirini
    Kafousopoulos, Dionysios
    Gkavogianni, Theologia
    Damoraki, Georgia
    Vatsellas, Giannis
    Giamarellos-Bourboulis, Evangelos J.
    JOURNAL OF INNATE IMMUNITY, 2024, 16 (01) : 1 - 11
  • [25] Association of vitamin D with the modulation of the disease severity in COVID-19
    Mardani, R.
    Alamdary, A.
    Nasab, S. D. Mousavi
    Gholami, R.
    Ahmadi, N.
    Gholami, A.
    VIRUS RESEARCH, 2020, 289
  • [26] Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation
    Parant, Francois
    Bouloy, Justin
    Haesebaert, Julie
    Bendim'red, Lamia
    Goldet, Karine
    Vanhems, Philippe
    Henaff, Laetitia
    Gilbert, Thomas
    Cuerq, Charlotte
    Blond, Emilie
    Bost, Muriel
    Bonnefoy, Marc
    NUTRIENTS, 2022, 14 (08)
  • [27] At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, Italy
    Novelli, Luca
    Raimondi, Federico
    Ghirardi, Arianna
    Pellegrini, Dario
    Capodanno, Davide
    Sotgiu, Giovanni
    Guagliumi, Giulio
    Senni, Michele
    Russo, Filippo M.
    Lorini, Ferdinando L.
    Rizzi, Marco
    Barbui, Tiziano
    Rambaldi, Alessandro
    Cosentini, Roberto
    Grazioli, Lorenzo S.
    Marchesi, Gianmariano
    Papa, Giuseppe F. Sferrazza
    Cesa, Simonetta
    Colledan, Michele
    Civiletti, Roberta
    Conti, Caterina
    Casati, Monica
    Ferri, Francesco
    Camagni, Stefania
    Sessa, Maria
    Masciulli, Arianna
    Gavazzi, Antonello
    Falanga, Anna
    Da Pozzo, Luigi F.
    Buoro, Sabrina
    Remuzzi, Giuseppe
    Ruggenenti, Piero
    Callegaro, Annapaola
    Lorenzo, D.
    Pasulo, Luisa
    Pezzoli, Fabio
    Gianatti, Andrea
    Parigi, Piercarlo
    Farina, Claudio
    Bellasi, Antonio
    Solidoro, Paolo
    Sironi, Sandro
    Di Marco, Fabiano
    Fagiuoli, Stefano
    PANMINERVA MEDICA, 2021, 63 (01) : 51 - 61
  • [28] Vitamin D: A Role Also in Long COVID-19?
    Barrea, Luigi
    Verde, Ludovica
    Grant, William B.
    Frias-Toral, Evelyn
    Sarno, Gerardo
    Vetrani, Claudia
    Ceriani, Florencia
    Garcia-Velasquez, Eloisa
    Contreras-Briceno, Jose
    Savastano, Silvia
    Colao, Annamaria
    Muscogiuri, Giovanna
    NUTRIENTS, 2022, 14 (08)
  • [29] Vitamin D: Implications in COVID-19
    Parvez, Sidrah
    Fatima, Ghizal
    Al-Awaida, Wajdy
    Hussien, Yasmeen Ali
    Al Tamam, Sara
    Hadi, Najah R.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (SI): : 23 - 26
  • [30] The role of vitamin D in cardiovascular disease and COVID-19
    Driggin, Elissa
    Madhavan, Mahesh, V
    Gupta, Aakriti
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2022, 23 (02) : 293 - 297